The Cigna Group (NYSE:CI) Given New $377.00 Price Target at Royal Bank of Canada

The Cigna Group (NYSE:CI) had its price objective lowered by analysts at Royal Bank of Canada from $384.00 to $377.00 in a report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the health services provider’s stock. Royal Bank of Canada’s price target indicates a potential upside of 19.12% from the stock’s current price.

Several other analysts have also commented on the stock. Jefferies Financial Group increased their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. JPMorgan Chase & Co. increased their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research report on Wednesday, August 21st. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, October 23rd. Finally, Barclays boosted their target price on The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $392.29.

The Cigna Group Trading Up 0.5 %

NYSE:CI opened at $316.49 on Friday. The firm has a 50-day simple moving average of $345.77 and a 200-day simple moving average of $341.51. The Cigna Group has a one year low of $253.95 and a one year high of $370.83. The firm has a market cap of $88.47 billion, a P/E ratio of 24.90, a P/E/G ratio of 0.95 and a beta of 0.50. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The Cigna Group’s revenue was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.77 earnings per share. Equities analysts anticipate that The Cigna Group will post 28.48 EPS for the current fiscal year.

Insider Transactions at The Cigna Group

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the transaction, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On The Cigna Group

Hedge funds have recently bought and sold shares of the stock. Cedar Wealth Management LLC purchased a new stake in shares of The Cigna Group during the 1st quarter worth about $29,000. TruNorth Capital Management LLC purchased a new position in The Cigna Group during the second quarter worth approximately $33,000. Ulland Investment Advisors LLC grew its holdings in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the period. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group in the third quarter valued at approximately $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of The Cigna Group during the 2nd quarter worth approximately $66,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.